Frost Radar™: Digital Biomarkers Through Connected Devices, 2020

Frost Radar™: Digital Biomarkers Through Connected Devices, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

RELEASE DATE
04-Dec-2020
REGION
Global
Research Code: D9D6-01-00-00-00
SKU: HC03361-GL-TR_25010

$4,950.00

Special Price $4,207.50 save 15 %

In stock
SKU
HC03361-GL-TR_25010

$4,950.00

$4,207.50 save 15 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

High prevalence of complex diseases, high investments and low success rate associated with drug development, are making the health industry appeal for innovative technologies that can enhance understanding of complex diseases, contribute to the development of personalized treatments, accelerate clinical trial activities, and lower the R&D expenditure of healthcare companies.
Digital biomarkers are quantifiable physiological and behavioral data of a person, which are collected by digital devices, such as wearables and implants to predict health-related outcomes. Digital biomarkers offer a great opportunity to acquire clinically meaningful and objective data, to better understand variations in human health and diseases. Digital biomarkers can be collected cost-effectively by digital or connected tools such as smart watches, smart bands, and wireless sensors.
In this benchmarking study, Frost & Sullivan has identified the top 12 key participants in the “Digital Biomarkers Through Connected Devices” space, as the leaders enabling the use of digital biomarkers in the healthcare industry.

Table of Contents

Strategic Imperative

Strategic Imperative (continued)

Introduction to Digital Biomarkers

Growth Environment

Growth Environment (continued)

Frost Radar™: Digital Biomarkers Through Connected Devices

Frost Radar™

Frost Radar™

Frost Radar™

ActiGraph

Apple

Biofourmis

Fitbit

GlySens

Kinsa Health

MC10

ResMed

Resmetrix Medical

Samsung

Shimmer

Verily

Strategic Insights

Significance of Being on the Frost Radar™

Frost Radar™ Empowers the CEO’s Growth Team

Frost Radar™ Empowers Investors

Frost Radar™ Empowers Customers

Frost Radar™ Empowers the Board of Directors

Frost Radar™: Benchmarking Future Growth Potential

Frost Radar™: Benchmarking Future Growth Potential

Legal Disclaimer

Related Research
High prevalence of complex diseases, high investments and low success rate associated with drug development, are making the health industry appeal for innovative technologies that can enhance understanding of complex diseases, contribute to the development of personalized treatments, accelerate clinical trial activities, and lower the R&D expenditure of healthcare companies. Digital biomarkers are quantifiable physiological and behavioral data of a person, which are collected by digital devices, such as wearables and implants to predict health-related outcomes. Digital biomarkers offer a great opportunity to acquire clinically meaningful and objective data, to better understand variations in human health and diseases. Digital biomarkers can be collected cost-effectively by digital or connected tools such as smart watches, smart bands, and wireless sensors. In this benchmarking study, Frost & Sullivan has identified the top 12 key participants in the “Digital Biomarkers Through Connected Devices” space, as the leaders enabling the use of digital biomarkers in the healthcare industry.
More Information
No Index No
Podcast No
Author Ashish Kaul
Industries Healthcare
WIP Number D9D6-01-00-00-00
Is Prebook No